Pfizer, Inc. (PFE) Tops Q1 EPS by 2c; Cuts FY12 Outlook

May 1, 2012 7:00 AM EDT
Pfizer, Inc. (NYSE: PFE) reported Q1 EPS of $0.58, $0.02 better than the analyst estimate of $0.56. Revenue for the quarter came in at $15.4 billion versus the consensus estimate of $15.47 billion.

Sees FY12 adj-EPS of $2.14-$2.24 on sales of $58-$60 billion. The Street is currently expecting FY12 EPS of $2.26 on sales of $62.14 billion. Pfizer had previously guided FY12 adj-EPS to $2.20-$2.30 on sales of $60.5-$62.5 billion.

For earnings history and earnings-related data on Pfizer, Inc. (PFE) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Guidance, Hot List

Related Entities


Add Your Comment